Research and new developments for lupus
We're the UK's biggest funder of research into lupus and are supporting a wide range of projects which aim to prevent the onset of lupus, transform its treatment and ultimately find a cure.
New therapeutic approaches which target cells and molecules believed to be part of the cause of lupus are being used to help many patients and further research studies should allow us to find out how these other drugs can be used to the best effect.
We're currently funding research into many aspects of lupus, including:
- studying the genetics of people with lupus in different parts of the world, to identify genes which increase an individual's risk of developing lupus
- whether rituximab, a drug that removes a type of immune cell called B cells from the circulation, is effective in people with lupus who have not responded to previous treatment
- why common genetic changes in the gene IKZF2 seem to increase an individual's risk of developing lupus
- whether a drug called belimumab can be used to treat people with lupus who do not respond to rituximab.
In addition, our Experimental Arthritis Treatment Centre for Children is trialling new and existing treatments in children with different forms of childhood arthritis and lupus.